Osteoradionecrosis
A condition of bone tissue death due to radiation exposure

Osteoradionecrosis (ORN) is a severe complication that can occur following radiation therapy, particularly in the treatment of head and neck cancers. It is characterized by the death of bone tissue due to the effects of radiation.
Pathophysiology[edit]
Osteoradionecrosis occurs when radiation damages the blood vessels that supply the bone, leading to a reduction in blood flow and subsequent bone necrosis. The mandible is the most commonly affected site due to its relatively poor blood supply compared to other bones in the head and neck region.
Clinical Presentation[edit]
Patients with osteoradionecrosis may present with pain, swelling, and exposed bone in the irradiated area. The condition can lead to secondary infections and may significantly impact the patient's quality of life.
Diagnosis[edit]
Diagnosis of osteoradionecrosis is primarily clinical, supported by imaging studies such as computed tomography (CT) or magnetic resonance imaging (MRI) to assess the extent of bone involvement.
Management[edit]
Management of osteoradionecrosis involves a multidisciplinary approach. Treatment options include:
- Conservative management with antibiotics and analgesics
- Surgical debridement of necrotic bone
- Hyperbaric oxygen therapy to enhance tissue healing
Prevention[edit]
Preventive measures are crucial in reducing the risk of osteoradionecrosis. These include:
- Pre-radiation dental evaluation and treatment
- Maintaining good oral hygiene
- Avoiding trauma to the irradiated area
Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian